Levonorgestrel-releasing intrauterine system: why do some women dislike it?

被引:21
|
作者
Daud, Suzanna [1 ]
Ewies, Ayman A. A. [1 ]
机构
[1] Ipswich Hosp NHS Trust, Dept Gynaecol, Ipswich IP4 5PD, Suffolk, England
关键词
Levonorgestrel-releasing intrauterine system; Mirena;
D O I
10.1080/09513590802444167
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. There is growing evidence of women's dissatisfaction with the levonorgestrel-releasing intrauterine system (LNG-IUS) because of a high incidence of adverse effects. Objective. To quantify the continuation rate and users' satisfaction, and identify symptoms associated with early removal before the 5-years effective life-time. Method. A questionnaire was sent to 212 women, who had LNG-IUS inserted from 1 January 1998 to 31 December 2003 at The Ipswich Hospital, UK. Results. The response rate was 76% (n = 161), 16 of the respondents were excluded and the data of 145 are presented. The continuation rate was 85%, 70%, 59%, 56%, 50% and 50% at 6 months, 1, 2, 3, 4 and 5 years, respectively. The total number of women who had the LNG-IUS removed before 5 years was 72 (50%), and the median duration of use was 270 days (range 4-1460). The reasons for early removal were unscheduled bleeding, progestogenic adverse effects, abdominal pain and others in 40 (28%), 32 (22%), 19 (13%) and 19 (13%) women, respectively. Only 73 (50%) women were satisfied with LNG-IUS. Conclusions. Our findings are similar to recent reports, and this information should be readily available to women to enable them to make an informed choice.
引用
收藏
页码:686 / 690
页数:5
相关论文
共 50 条
  • [1] Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis
    Shen Lan
    Liu Ling
    Zhao Jianhong
    Jiang Xijing
    Wang Lihui
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (03) : 548 - 558
  • [2] Breast levonorgestrel concentrations in women using a levonorgestrel-releasing intrauterine system
    Depypere, Herman T.
    Stanczyk, Frank Z.
    Croubels, Siska
    Blondeel, Phillip N.
    Roche, Nathalie A.
    Depypere, Bernard P.
    Vanhaecke, Lynn
    CONTRACEPTION, 2019, 100 (04) : 299 - 301
  • [3] The levonorgestrel-releasing intrauterine system for menorrhagia
    Lewis, P
    Selvakumari, NK
    Neelapalla, S
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (01): : 46 - 46
  • [4] Mirena - Levonorgestrel-releasing intrauterine system
    不详
    FORMULARY, 2001, 36 (02) : 93 - 93
  • [5] Influences on women's choice of the levonorgestrel-releasing intrauterine system
    Binkowska, Malgorzata
    Harvey, Thierry
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2010, 36 (04): : 254 - 254
  • [6] Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders
    Lukes, Andrea S.
    Reardon, Beth
    Arepally, Gowthami
    FERTILITY AND STERILITY, 2008, 90 (03) : 673 - 677
  • [7] Uterine perforation in women using a levonorgestrel-releasing intrauterine system
    Van Houdenhoven, K
    van Kaam, K
    van Grootheest, AC
    Salemans, THB
    Dunselman, GAJ
    CONTRACEPTION, 2006, 73 (03) : 257 - 260
  • [8] Gynaecological aspects of the levonorgestrel-releasing intrauterine system
    Sturridge, F
    Guillebaud, J
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (03): : 285 - 289
  • [9] Levonorgestrel-releasing intrauterine system: uses and controversies
    Bahamondes, Luis
    Bahamondes, M. Valeria
    Monteiro, Ilza
    EXPERT REVIEW OF MEDICAL DEVICES, 2008, 5 (04) : 437 - 445
  • [10] Levonorgestrel-releasing intrauterine system (Mirena) for contraception
    McCarthy, Lisa
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (10) : 1799 - 1801